NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $47.64 -0.22 (-0.46%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$46.64▼$48.8050-Day Range$38.20▼$52.4852-Week Range$28.86▼$54.27Volume200,144 shsAverage Volume178,850 shsMarket Capitalization$2.67 billionP/E Ratio36.09Dividend YieldN/APrice Target$59.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Get Astrana Health alerts: Email Address Astrana Health MarketRank™ Stock AnalysisAnalyst RatingBuy3.20 Rating ScoreUpside/Downside23.8% Upside$59.00 Price TargetShort InterestBearish6.77% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.98Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth24.44%From $1.35 to $1.68 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.60 out of 5 starsMedical Sector413th out of 910 stocksManagement Consulting Services Industry11th out of 14 stocks 2.6 Analyst's Opinion Consensus RatingAstrana Health has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAstrana Health has only been the subject of 3 research reports in the past 90 days.Read more about Astrana Health's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.77% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.Change versus previous monthShort interest in Astrana Health has recently decreased by 6.04%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASTH. Previous Next 2.8 News and Social Media Coverage News SentimentAstrana Health has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Astrana Health this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added Astrana Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.46% of the stock of Astrana Health is held by insiders.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Astrana Health are expected to grow by 24.44% in the coming year, from $1.35 to $1.68 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 36.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 36.09, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.64.Price to Earnings Growth RatioAstrana Health has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 3.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. About Astrana Health Stock (NASDAQ:ASTH)Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Read More ASTH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASTH Stock News HeadlinesSeptember 2, 2024 | finance.yahoo.comIs Astrana Health, Inc.'s (NASDAQ:ASTH) Latest Stock Performance A Reflection Of Its Financial Health?August 29, 2024 | markets.businessinsider.comAstrana Health’s Earnings Growth Potential Through RAF Score Enhancement: A Buy Rating AnalysisSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.August 28, 2024 | americanbankingnews.comReviewing FTI Consulting (NYSE:FCN) and Astrana Health (NASDAQ:ASTH)August 22, 2024 | prnewswire.comAstrana Health, Inc. to Participate in Upcoming Investor ConferencesAugust 17, 2024 | finance.yahoo.comAstrana Health's (NASDAQ:ASTH) Strong Earnings Are Of Good QualityAugust 9, 2024 | markets.businessinsider.comAstrana Health’s Strong Q2 Performance and Strategic Growth Fuel Buy RatingAugust 8, 2024 | msn.comAstrana Health, Inc. (NASDAQ:ASTH) Q2 2024 Earnings Call TranscriptSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.August 8, 2024 | msn.comDoes Astrana Health (ASTH) Have a Long Runway for Growth?August 7, 2024 | prnewswire.comAstrana Health, Inc. Reports Second Quarter 2024 ResultsAugust 5, 2024 | finance.yahoo.comWhat Does Astrana Health, Inc.'s (NASDAQ:ASTH) Share Price Indicate?July 26, 2024 | markets.businessinsider.comTruist Financial Keeps Their Buy Rating on Astrana Health (ASTH)July 26, 2024 | finance.yahoo.comASTH Aug 2024 20.000 call (ASTH240816C00020000)July 25, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and REPRO-MED Systems (KRMD)July 25, 2024 | prnewswire.comAstrana Health Enters Definitive Agreement to Acquire Collaborative Health SystemsJuly 23, 2024 | prnewswire.comAstrana Health, Inc. Schedules 2024 Second Quarter Financial Results Release and Conference CallJuly 19, 2024 | marketwatch.comAstrana, Elation Form Partnership to Expand Support for Primary Care PhysiciansSee More Headlines Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2024Today9/07/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Management consulting services Sub-IndustryBusiness Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CUSIPN/A CIK1083446 Webwww.apollomed.net Phone626-282-0288Fax818-839-5190Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$59.00 High Stock Price Target$67.00 Low Stock Price Target$50.00 Potential Upside/Downside+23.8%Consensus RatingBuy Rating Score (0-4)3.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$1.32 Trailing P/E Ratio36.09 Forward P/E Ratio35.29 P/E Growth1.77Net Income$60.72 million Net Margins4.30% Pretax Margin5.96% Return on Equity10.71% Return on Assets6.10% Debt Debt-to-Equity Ratio0.62 Current Ratio1.84 Quick Ratio1.84 Sales & Book Value Annual Sales$1.59 billion Price / Sales1.68 Cash Flow$1.36 per share Price / Cash Flow35.02 Book Value$13.92 per share Price / Book3.42Miscellaneous Outstanding Shares56,026,000Free Float51,286,000Market Cap$2.67 billion OptionableOptionable Beta1.16 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Kenneth T. Sim M.D. (Age 69)Co-Founder & Executive Chairman Comp: $1.49MMr. Brandon K. Sim M.S. (Age 30)President & CEO Comp: $1.73MDr. Thomas S. Lam M.D. (Age 75)M.P.H., Co-Founder & Vice Chairman Comp: $1.49MMr. Chandan Basho M.B.A. (Age 41)CFO & COO Comp: $581.42kDr. WaiChow Young M.D. (Age 76)M.P.H., Chief Administrative Officer Comp: $573.67kMr. John Vong CPA (Age 51)CGMA, M.B.A., Chief Accounting Officer Ms. Rita Pew M.B.A.Vice President of People & OperationsDr. Jeremy R. Jackson M.D.Chief Quality OfficerMr. Neil AhujaPresident of Provider SolutionsDr. Carlos Palacios M.D.Chief Medical Officer for TexasMore ExecutivesKey CompetitorsMaplebearNASDAQ:CARTStantecNYSE:STNGlobantNYSE:GLOBHealthEquityNASDAQ:HQYEtsyNASDAQ:ETSYView All Competitors ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $42.79 at the start of the year. Since then, ASTH stock has increased by 11.3% and is now trading at $47.64. View the best growth stocks for 2024 here. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) issued its quarterly earnings results on Wednesday, August, 7th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.01. The firm's quarterly revenue was up 39.7% on a year-over-year basis. How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ASTH) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.